Remove Molecular Biology Remove Vaccine Remove Virus
article thumbnail

Optimizing your ELISA Assays | BMG LABTECH

BMG Labtech

This is reflected in scientific discoveries across many research disciplines including immunology , molecular biology , medicine, and diagnostics. Specific areas where they have had a wide impact include virology , bacteriology, biotechnology , fungal biology, cancer and oncology (e.g.

Vaccine 98
article thumbnail

Dr. Reno Pontarollo named President and COO of Eyam Vaccines and Immunotherapeutics

The Pharma Data

” VANCOUVER, BC, December 02, 2020 /24-7PressRelease/ — Eyam Vaccines and Immunotherapeutics (EYAM) today announced that former President and CEO of Genome Prairie is joining EYAM. Dr. Pontarollo’s primary areas of research and technical expertise include Genomics, Molecular Biology, Vaccine development and Immunology.

Vaccine 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Repurposing FDA-approved drugs may help combat COVID-19

The Pharma Data

“The SARS-CoV-2 vaccines target the spike protein, but this protein is under strong selection pressure and, as we have seen with Omicron, can undergo significant mutations,” said Joyce Jose, assistant professor of biochemistry and molecular biology, Penn State. 25) in the journal Communications Biology. .

article thumbnail

Roche launches new quantitative antibody test to measure SARS-CoV-2 antibodies, to support the evaluation of vaccines

The Pharma Data

The new Elecsys Anti-SARS-CoV-2 S test can quantitatively measure the level of antibodies against SARS-CoV-2 in patients who have been exposed to the virus. This is the focus of vaccines in development and convalescent plasma therapy. The test targets antibodies against the spike protein. said Thomas Schinecker, CEO Roche Diagnostics.

Vaccine 52
article thumbnail

Enhancing gene therapy with Circio

Drug Target Review

In parallel, we are exploring the technical performance of circVec in other viral vectors, as well as non-viral approaches which we expect will surpass virus-based vector-format as the state-of-the-art solutions for gene therapy in the future. So far, we have successfully expressed circRNA from six different vector types.

article thumbnail

Otto Bayer Award goes to Prof. Ruth Ley PhD

The Pharma Data

Before, she was associate professor at Cornell University in the Department of Molecular Biology and Genetics. Now we are on the brink of a vaccination program of historic scale. It has the potential to boost trust in science and vice versa, it needs trust to get large parts of the population vaccinated.

article thumbnail

Merkin Prize in Biomedical Technology awarded to F. William Studier for development of widely used protein- and RNA-production platform

Broad Institute

The approach has been used to produce numerous therapeutics, diagnostics, and vaccines — including the COVID-19 mRNA vaccines credited with extending millions of lives in recent years. “F. There’s not a single molecular biology or biochemistry lab I know that doesn’t use T7.” and around the world.

RNA 84